sever
acut
respiratori
syndrom
coronaviru
caus
global
pandem
novel
corona
viru
diseas
date
prophylact
vaccin
approv
therapeut
agent
avail
prevent
treat
highli
transmitt
diseas
report
two
monoclon
antibodi
mab
clone
memori
b
cell
patient
recent
recov
mab
specif
bind
spike
protein
block
bind
receptor
bind
domain
rbd
human
angiotensin
convert
enzym
effect
neutral
proteinpseudotyp
viru
infect
human
mab
hold
promis
prevent
treatment
ongo
pandem
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
main
text
accord
world
health
organ
newli
updat
situat
report
march
th
corona
viru
diseas
pandem
confirm
case
claim
death
worldwid
etiolog
agent
identifi
novel
coronaviru
sever
acut
respiratori
syndrom
coronaviru
belong
sarbecoviru
subgenu
genu
betacoronaviru
famili
coronavirida
show
sequenc
ident
nucleotid
sarscov
bat
coronaviru
batcov
respect
like
sarscov
infect
substanti
fraction
patient
exhibit
sever
respiratori
symptom
hospit
intens
care
unit
icu
although
mortal
rate
significantli
lower
sarscov
infect
show
much
higher
humantohuman
transmiss
rate
rapidli
lead
global
pandem
declar
march
th
current
approv
prophylact
vaccin
therapeut
drug
specif
block
monoclon
antibodi
mab
due
extraordinari
antigen
specif
one
best
candid
neutral
viru
infect
therefor
identifi
clone
block
mab
specif
target
surfac
viral
protein
block
viral
entri
host
cell
attract
approach
prevent
treat
particular
effect
vaccin
therapeut
unavail
outbreak
pandem
sought
identifi
clone
block
mab
memori
b
cell
repertoir
recent
recov
patient
prevent
entri
viru
host
cell
similar
sarscov
also
util
highli
glycosyl
homotrimer
spike
protein
receptor
bind
viru
entri
protein
consist
two
subunit
engag
host
cell
receptor
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
human
angiotensinconvert
enzym
share
sarscov
protein
undergo
dramat
conform
chang
expos
rbd
key
residu
receptor
bind
protein
metast
bind
rbd
receptor
like
lead
shed
protein
protein
thu
promot
virushost
membran
fusion
viru
entri
given
critic
role
rbd
initi
invas
host
cell
becom
vulner
target
neutral
antibodi
thu
far
human
mab
specif
target
interact
report
monoclon
antibodi
target
made
immun
transgen
mice
express
human
ig
variabl
heavi
light
chain
recent
shown
neutral
sarscov
infect
unknown
mechan
independ
blockad
interact
prior
clone
rbd
specif
human
mab
first
examin
whether
patient
recent
recov
mount
protein
igg
antibodi
sera
among
recov
patient
found
major
recruit
patient
abl
produc
high
titer
igg
antibodi
patient
mount
rel
lower
igg
respons
enzymelink
immunosorb
assay
elisa
fig
consist
also
found
rbd
specif
igg
antibodi
present
sera
patient
elisa
fig
next
sought
investig
whether
rbdspecif
antibodi
patient
serum
block
bind
rbd
end
set
elisabas
inhibit
assay
examin
block
function
antibodi
note
patient
show
effect
blockad
rbd
bind
fig
taken
togeth
result
suggest
recov
patient
gener
antirbd
antibodi
small
fraction
antibodi
block
bind
rbd
receptor
observ
may
explain
transient
dynam
perfus
conform
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
state
protein
provid
limit
window
immunogen
epitop
rbd
exposur
specif
b
cell
next
set
clone
human
monoclon
antibodi
use
blood
sampl
three
recov
patient
sera
show
potent
receptor
bind
inhibit
end
sort
rbd
specif
igg
classswitch
memori
b
cell
singl
well
micropl
subsequ
use
revers
transcript
polymeras
chain
reaction
rtpcr
amplifi
igg
variabl
heavi
chain
vh
light
chain
vl
singl
memori
b
cell
clone
vh
vl
insert
sequenc
express
plasmid
encod
constant
region
human
heavi
chain
light
chain
suggest
specif
sort
strategi
repres
rtpcr
clone
heavi
chain
light
chain
express
plasmid
shown
figur
antibodi
clone
acquir
pair
igg
vh
vl
insert
express
plasmid
sequenc
heavi
chain
shown
figur
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
inhibit
interact
also
evidenc
flow
cytometri
analysi
fig
furthermor
determin
neutral
three
mab
use
pseudotyp
lentivir
particl
line
elisa
flow
cytometrybas
blockad
result
effect
neutral
pseudoviru
entri
host
cell
ectop
express
ic
respect
expect
clone
fail
show
neutral
activ
fig
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
wrote
paper
xc
rl
pl
yc
zq
xz
yw
kd
zzo
ly
yk
zq
supervis
studi
author
declar
compet
interest
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
biolog
pb
per
well
coat
elisa
plate
overnight
c
elisa
plate
block
hour
block
buffer
fb
plu
tween
meanwhil
threefold
serial
dilut
mab
tenfold
dilut
patient
sera
incub
optim
dose
base
ec
rbd
protein
sino
biolog
hour
incub
mixtur
ad
elisa
plate
allow
develop
min
follow
pbst
wash
antimous
fc
hrp
antibodi
thermo
fisher
scientif
next
elisa
plate
wash
pbst
pb
ad
tmb
beyotim
min
elisa
plate
stop
determin
nm
half
maxim
inhibitori
concentr
ic
determin
use
logist
regress
flow
inhibit
assay
mab
isotyp
incub
optim
dose
base
ec
rbd
protein
sino
biolog
hour
rt
mixtur
incub
transient
transfect
cell
min
ice
follow
stain
alexa
fluor
goat
antimous
igg
biolegend
livedead
dye
life
technolog
pseudoviru
neutral
assay
spike
protein
type
pseudoviru
produc
previous
describ
concis
cell
transfect
plentigfp
plasmid
use
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
repres
two
independ
experi
three
replic
per
group
b
dfo
error
bar
b
df
indic
sd
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
isotyp
